These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9652851)

  • 1. In vitro radiosensitization of human cervical carcinoma cells by combined use of 13-cis-retinoic acid and interferon-alpha2a.
    Ryu S; Kim OB; Kim SH; He SQ; Kim JH
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):869-73. PubMed ID: 9652851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced apoptosis and radiosensitization by combined 13-cis-retinoic acid and interferon-alpha2a; role of RAR-beta gene.
    Ryu S; Stein JP; Chung CT; Lee YJ; Kim JH
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):785-90. PubMed ID: 11697325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination interferon-alpha2a and 13-cis-retinoic acid enhances radiosensitization of human malignant glioma cells in vitro.
    Malone C; Schiltz PM; Nayak SK; Shea MW; Dillman RO
    Clin Cancer Res; 1999 Feb; 5(2):417-23. PubMed ID: 10037192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.
    Motzer RJ; Schwartz L; Law TM; Murphy BA; Hoffman AD; Albino AP; Vlamis V; Nanus DM
    J Clin Oncol; 1995 Aug; 13(8):1950-7. PubMed ID: 7636535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 2-week pretreatment with 13-cis-retinoic acid + interferon-alpha-2a prior to definitive radiation improves tumor tissue oxygenation in cervical cancers.
    Dunst J; Hänsgen G; Krause U; Füchsel G; Köhler U; Becker A
    Strahlenther Onkol; 1998 Nov; 174(11):571-4. PubMed ID: 9830438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon.
    Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of fractionated-dose irradiation by retinoic acid plus interferon.
    Gerweck LE; Zaidi ST; Delaney TF
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):611-5. PubMed ID: 9806522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 13-cis-retinoic acid with alpha-2a-interferon enhances radiation cytotoxicity in head and neck squamous cell carcinoma in vitro.
    DeLaney TF; Afridi N; Taghian AG; Sanders DA; Fuleihan NS; Faller DV; Nogueira CP
    Cancer Res; 1996 May; 56(10):2277-80. PubMed ID: 8625298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma.
    Dillman RO; Shea WM; Tai DF; Mahdavi K; Barth NM; Kharkar BR; Poor MM; Church CK; DePriest C
    Neuro Oncol; 2001 Jan; 3(1):35-41. PubMed ID: 11305415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of retinoic acid and interferon in renal cancer cell lines.
    Nanus DM; Geng Y; Shen R; Lai HK; Pfeffer SR; Pfeffer LM
    J Interferon Cytokine Res; 2000 Sep; 20(9):787-94. PubMed ID: 11032398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid inhibits the growth of human myeloma cells in vitro.
    Palumbo A; Battaglio S; Napoli P; Bruno B; Omedè P; Boccadoro M; Pileri A
    Br J Haematol; 1995 Mar; 89(3):555-60. PubMed ID: 7734354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 13-cis retinoic acid in combination with interferon-alpha enhances radiation sensitivity of human squamous cell carcinoma cells of the oral cavity.
    Bläse M; Zaruba MM; Santo-Hoeltje L; Bamberg M; Hoffmann W; Rodemann HP
    Strahlenther Onkol; 1999 Nov; 175(11):563-8. PubMed ID: 10584127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cell cycle arrest and apoptosis by a combined treatment with 13-cis-retinoic acid, interferon-alpha2a, and alpha-tocopherol in squamous cell carcinoma of the head and neck.
    Zhang X; Chen ZG; Khuri FR; Shin DM
    Head Neck; 2007 Apr; 29(4):351-61. PubMed ID: 17163463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic anti-tumor effect of 13-cRA and IFN-alpha/beta in mouse renal cell carcinoma.
    Taguchi I; Hara I; Gohji K; Arakawa S; Kamidono S
    Int J Oncol; 1998 Jul; 13(1):145-9. PubMed ID: 9625816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The additive antiproliferative effect of all-trans retinoic acid and interferon-alpha2a on human cervical carcinoma cell lines is not associated with increased expression of retinoid receptors.
    Wahlberg P; Einarsdottir M; Fex G; Rydell R
    Anticancer Drugs; 1997 Jun; 8(5):522-8. PubMed ID: 9215617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estramustine: a novel radiation enhancer in human carcinoma cells.
    Ryu S; Gabel M; Khil MS; Lee YJ; Kim SH; Kim JH
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):99-104. PubMed ID: 7916009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines.
    Majewski S; Szmurlo A; Marczak M; Jablonska S; Bollag W
    Int J Cancer; 1994 Apr; 57(1):81-5. PubMed ID: 7512078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells.
    Lancillotti F; Giandomenico V; Affabris E; Fiorucci G; Romeo G; Rossi GB
    Cancer Res; 1995 Jul; 55(14):3158-64. PubMed ID: 7606736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell lines.
    Angioli R; Sevin BU; Perras JP; Untch M; Koechli OR; Nguyen HN; Steren A; Schwade JG; Villani C; Averette HE
    Cancer; 1993 Jun; 71(11):3717-25. PubMed ID: 8490922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha and all-trans-retinoic acid reversibly inhibit the in vitro proliferation of cell lines derived from cervical cancers.
    Massad LS; Turyk ME; Bitterman P; Wilbanks GD
    Gynecol Oncol; 1996 Mar; 60(3):428-34. PubMed ID: 8774652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.